Neogenomics, Inc.
NEO
$16.24
$0.402.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -51.88M | -99.21M | -108.03M | -113.47M | -104.04M |
| Total Depreciation and Amortization | 65.78M | 66.52M | 67.83M | 69.62M | 71.17M |
| Total Amortization of Deferred Charges | 1.54M | 2.00M | 2.00M | 2.35M | 2.70M |
| Total Other Non-Cash Items | 39.39M | 74.17M | 75.52M | 75.71M | 67.03M |
| Change in Net Operating Assets | -32.78M | -21.06M | -32.10M | -20.53M | -22.81M |
| Cash from Operations | 22.05M | 22.42M | 5.23M | 13.69M | 14.05M |
| Capital Expenditure | -29.40M | -27.51M | -27.01M | -30.74M | -33.22M |
| Sale of Property, Plant, and Equipment | 2.07M | 2.07M | 2.07M | -- | -- |
| Cash Acquisitions | -463.00K | -6.45M | -6.45M | -6.45M | -5.99M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.90M | 11.00M | 19.06M | 25.69M | 24.48M |
| Cash from Investing | -19.90M | -20.90M | -12.34M | -11.50M | -14.74M |
| Total Debt Issued | 305.43M | -- | -- | -- | -- |
| Total Debt Repaid | -264.20M | -201.26M | -201.26M | -201.26M | -201.26M |
| Issuance of Common Stock | 3.99M | 2.35M | 3.30M | 6.41M | 7.06M |
| Repurchase of Common Stock | -28.17M | -2.57M | -2.57M | -2.57M | -2.57M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -28.44M | -104.00K | 234.00K | -2.62M | -2.86M |
| Cash from Financing | -11.39M | -201.58M | -200.29M | -200.03M | -199.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 54.00K | 0.00 | 0.00 | -32.00K | -54.00K |
| Net Change in Cash | -9.18M | -200.05M | -207.39M | -197.88M | -200.36M |